Another 31 (10.8%) discontinued for other reasons, and the discontinuation reason was not specified in the EHR for 32 (11.1%) patients
Expected results timeline Be realistic about timing
doi:10.1371/journal.pone.0119479 Veronese N, Sergi G, Stubbs B, The EUGMS special interest group on diabetes, Bourdel-Marchasson I, Tessier D, Sieber C, Strandberg T, Gillain S, Barbagallo M, Crepaldi G, Maggi S, Manzato E (2017) Effect of acetyl-l-carnitine in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis
Documented HSDD with measurable distress
Draw using the visual syringe guide
See a dermatologist before starting any new medications or if you notice pigmentation changes